The goal of the Pilot and Feasibility Study Program is to encourage research on diabetes and its complications by two target groups: young researchers in these fields who have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction.
We are now requesting applications for grants to begin January, 2014. Two grants will be awarded to researchers based either at the Joslin Diabetes Center or at neighboring institutions within Harvard Medical School and affiliated hospitals. The second year of funding is contingent on successful completion of the first year as outlined in a submitted progress report. A special effort is made to foster interactions between Joslin DERC investigators and the external P&F Study Program awardees. This includes facilitating access to Joslin DERC cores, an invitation to give a seminar in the Joslin internal research seminar series, and invitations to Joslin retreats and other enrichment activities. Please visit the Enrichment Core.
The program has been highly successful since its inception. Projects funded in past years have covered a wide range of topics in the fields of type 1 and type 2 diabetes and their complications, including the control of insulin gene expression, mechanisms of insulin action and resistance, stem cell biology, beta cell apoptosis and potential renewal, mechanisms of leptin action and resistance, and autoantigen therapy of type 1 diabetes. The approaches have also been very diverse, covering wide varieties of biochemical, molecular biologic, genetic, immunological and clinical strategies. This breadth reflects the interests of Joslin’s diabetes research program as a whole; see more about Joslin’s Research Programs.
The application process is a two-step procedure. By midnight of October 25, 2013, the potential candidate should submit an electronic “Letter of Intent.” Received letters will be pre-reviewed for eligibility and priority, and the successful candidates will be asked to electronically submit a five-page proposal following an abbreviated version of a standard NIH application, due by November 22, 2013. These applications will be reviewed and awarded P&Fs will be selected for funding to start on January 1, 2014.
For further questions about the grant and the application process, email: PandF@Joslin.Harvard.Edu.
Deadline for Letter of Intent: October 25, 2013
Deadline for Full Application (invitation only):November 22, 2013
Decision Announcement: No later than January 15, 2014
Funding Cycle: Begins January 1, 2014 and lasts 1 year. A second year of funding is contingent upon positive review of the P&F year 1 progress report.